Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Diabetes and Endocrinology
  • Diabetes and Endocrinology News
  • Semaglutide advisable...

Semaglutide advisable option for preservation of beta cell function in diabetes patients

AditiWritten by Aditi Published On 2023-02-08T11:15:56+05:30  |  Updated On 8 Feb 2023 6:47 AM GMT
Semaglutide advisable option for preservation of beta cell function in diabetes patients
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • koo
  • Email

Italy: An original research article published in Frontiers in Endocrinology has mentioned that Semaglutide preserves the functioning of β-cell. It may have disease-modifying actions on insulin resistance (HOMA-IR) and prediabetes and Type 2 Diabetes. Dr Berra et al. and the team from the Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy, evaluated the...

Italy: An original research article published in Frontiers in Endocrinology has mentioned that Semaglutide preserves the functioning of β-cell. It may have disease-modifying actions on insulin resistance (HOMA-IR) and prediabetes and Type 2 Diabetes.

Dr Berra et al. and the team from the Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy, evaluated the real-world impact of once-weekly (OW) subcutaneous semaglutide on different end-points indicating metabolic control, cardiovascular (CV) risk factors, and beta-cell function in T2D.

The researchers did this study in five diabetes clinics in Italy. During 12 months, they evaluated HbA1c, fasting blood glucose (FBG), weight, BP, lipid profile, kidney function, and beta-cell function (HOMA-B).

The results of the study could be summarised as follows:

  • The study included 594 patients with a mean age of 63.9 years, with 58.7% men.
  • The duration of diabetes was 11.4 ± 8.0 years.
  • After giving OW semaglutide for six months, HbA1c levels were reduced by 0.90%, FBG by 26 mg/dl, and body weight by 3.43 kg. There was improvement reported in Systolic blood pressure and cholesterol (total and LDL-).
  • There were more benefits at 12 months.
  • Renal safety was confirmed as Renal parameters like eGFR and ACR remained unchanged after 12 months of treatment.
  • There was an increase in HOMA-B after six months from 40.2% to 57.8%.

The researchers discussed that semaglutide benefits metabolic control, multiple cardiovascular risk factors, and renal safety in the real world.

It modifies insulin resistance (HOMA-IR).

Our study confirms the effectiveness of OW semaglutide in a high CV-risk real-world cohort of patients with uncontrolled T2DM. The findings align with existing knowledge in the context of improvement in Fasting Blood Glucose, Body Mass Index, total and LDL cholesterol, and triglycerides.

Further reading:

Berra, Cesare C., et al. “Real World Effectiveness of Subcutaneous Semaglutide in Type 2 Diabetes: A Retrospective, Cohort Study (Sema-MiDiab01).” Frontiers in Endocrinology, vol. 13, Frontiers Media SA, Jan. 2023. Crossref, https://doi.org/10.3389/fendo.2022.1099451.

semaglutidediabetesHOMA-IRprediabetestype2 diabetesFrontiers in Endocrinologyrenal functionmetabolic controlcardiovascular risk factorsT2DM
Source : Frontiers in Endocrinology
Aditi
Aditi

    BDS,MDS in Periodontics and Implantology

    Dr. Aditi Yadav is a BDS, MDS in Periodontics and Implantology. She has a clinical experience of 5 years as a laser dental surgeon. She also has a Diploma in clinical research and pharmacovigilance and is a Certified data scientist. She is currently working as a content developer in e-health services. Dr. Yadav has a keen interest in Medical Journalism and is actively involved in Medical Research writing.

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Journal Club Today

    Health News Today

    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    X